a must listen for all shareholders. The downside risks the key takeaway point. Remarkable progress, unprecedented upward demand curve for product (including cathode) and their expanding research and developmental capacity to meet same albeit production forever so monstrously behind the curve. If they can achieve their targets the share price will look after itself.
- Forums
- ASX - By Stock
- NVX
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-3
Featured News
Add NVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
81.3¢ |
Change
0.003(0.31%) |
Mkt cap ! $397.4M |
Open | High | Low | Value | Volume |
82.5¢ | 85.5¢ | 79.5¢ | $3.321M | 4.018M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10964 | 81.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
81.5¢ | 55489 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 122623 | 0.800 |
12 | 115293 | 0.795 |
14 | 160508 | 0.790 |
8 | 177649 | 0.785 |
10 | 248847 | 0.780 |
Price($) | Vol. | No. |
---|---|---|
0.805 | 5561 | 2 |
0.810 | 49807 | 9 |
0.815 | 118992 | 8 |
0.825 | 37669 | 4 |
0.830 | 100159 | 6 |
Last trade - 14.46pm 12/11/2024 (20 minute delay) ? |
Featured News
NVX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online